Northwestern Mutual Wealth Management’s Actuate Therapeutics ACTU Stock Holding History
Bought
Maintained
Sold
Other funds holding ACTU
Northwestern Mutual Wealth Management's ACTU Position: Q3 2026 in Review
Northwestern Mutual Wealth Management held its Actuate Therapeutics (ACTU) position steady in Q3 2026 at 18,518 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3058.
Northwestern Mutual Wealth Management first reported a position in ACTU in Q1 2025 and has held it in 7 quarters since. The position peaked at $129K in Q3 2025. 40 funds tracked by Wall St. Rank hold ACTU as of Q3 2026.
- Northwestern Mutual Wealth Management held 18,518 shares of Actuate Therapeutics worth $14.4K as of Q3 2026.
- Northwestern Mutual Wealth Management left its Actuate Therapeutics share count unchanged in Q3 2026.
- Actuate Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q3 2026, its #3058 holding.
- Northwestern Mutual Wealth Management first reported a position in Actuate Therapeutics in Q1 2025 and has held it in 7 quarters since.
- Northwestern Mutual Wealth Management's Actuate Therapeutics position peaked at $129K in Q3 2025.
- 40 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q3 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.